Which has grown faster, CCCC or IRD?

Over the past five years, IRD grew revenue faster — CCCC at a 0.65% CAGR versus IRD at 150.49%.

C4 Therapeutics, Inc. (CCCC) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of C4 Therapeutics, Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CCCC

C4 Therapeutics, Inc.

$313M

$2.84HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

IRD

Opus Genetics, Inc.

$364M

$4.40HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — CCCC vs IRD

growth of $100 · dividends reinvested · last 2y

CCCC -52.2% (-30.9%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window

Log scale — wide-divergence pair

CCCC IRD

CCCC vs IRD: by the numbers

•IRD is the larger company ($364M vs $313M market cap).
•Both run net losses; CCCC's is the smaller (-289.44% vs -1091.82% net margin).
•IRD grew revenue faster over the past five years (150.49% vs 0.65% CAGR).

Metrics side by side

Valuation

Metric	CCCC	IRD
P/S ratio	8.95	36.88
P/B ratio	1.27	N/A

Profitability

Metric	CCCC	IRD
Gross margin	77.81%	99.87%
Operating margin	-290.68%	-271.90%
Net margin	-289.44%	-1091.82%
ROE	-41.02%	N/A
ROIC	-35.92%	-59.29%

Growth (annualized)

Metric	CCCC	IRD
Revenue CAGR (5Y)	0.65%	150.49%
Total return CAGR (5Y)	-41.77%	N/A

Frequently asked

Which has grown faster, CCCC or IRD?: Over the past five years, IRD grew revenue faster — CCCC at a 0.65% CAGR versus IRD at 150.49%.

Go deeper

Full CCCC analysis Full IRD analysis Interactive comparison tool

Dig into the metrics

C4 Therapeutics ROE Opus Genetics ROE C4 Therapeutics operating margin Opus Genetics operating margin C4 Therapeutics revenue growth Opus Genetics revenue growth C4 Therapeutics free cash flow Opus Genetics free cash flow

C4 Therapeutics & Opus Genetics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.